Natasa Kragic

Natasa Kragic is a seasoned professional in the biopharmaceutical industry, currently serving as the Business Unit Manager for the Celltrion Biosimilars Business Unit at Oktal Pharma since August 2023. Prior experience includes a distinguished tenure at Novartis from September 2011 to July 2023, where Natasa held various leadership roles, including Franchise Head for Cardio-Renal-Metabolic and Respiratory, as well as Senior Brand Manager. Additional experience includes positions at PharmaSwiss and Novartis in product management and medical representation. Natasa’s educational background includes a Doctor of Medicine (MD) and a Postgraduate Specialist Degree in Leadership and Management in Health Services, both attained from the School of Medicine University of Zagreb.